Current CDC travel health notices show no active Level 4 designations as of late May 2026, reflecting the absence of extreme global health risks that would justify “Avoid All Travel” advisories under agency criteria. Ongoing Ebola outbreaks in East and Central Africa have prompted targeted entry screening and 30-day restrictions rather than broad Level 4 notices, while dengue and polio alerts remain at Levels 1–2. With no confirmed surges meeting the extreme-risk threshold and routine surveillance indicating contained transmission, traders assign a 76.5% implied probability against issuance by December 31, consistent with historical patterns where Level 4 warnings have been reserved for exceptional, rapidly escalating threats.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日はい
$71,630 Vol.
$71,630 Vol.
2026/12/31
はい
$71,630 Vol.
$71,630 Vol.
2026/12/31
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Current CDC travel health notices show no active Level 4 designations as of late May 2026, reflecting the absence of extreme global health risks that would justify “Avoid All Travel” advisories under agency criteria. Ongoing Ebola outbreaks in East and Central Africa have prompted targeted entry screening and 30-day restrictions rather than broad Level 4 notices, while dengue and polio alerts remain at Levels 1–2. With no confirmed surges meeting the extreme-risk threshold and routine surveillance indicating contained transmission, traders assign a 76.5% implied probability against issuance by December 31, consistent with historical patterns where Level 4 warnings have been reserved for exceptional, rapidly escalating threats.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
マーケット開始日： Jan 19, 2026, 3:15 PM ET
音量
$71,630終了日
2026/12/31マーケット開始日
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Current CDC travel health notices show no active Level 4 designations as of late May 2026, reflecting the absence of extreme global health risks that would justify “Avoid All Travel” advisories under agency criteria. Ongoing Ebola outbreaks in East and Central Africa have prompted targeted entry screening and 30-day restrictions rather than broad Level 4 notices, while dengue and polio alerts remain at Levels 1–2. With no confirmed surges meeting the extreme-risk threshold and routine surveillance indicating contained transmission, traders assign a 76.5% implied probability against issuance by December 31, consistent with historical patterns where Level 4 warnings have been reserved for exceptional, rapidly escalating threats.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
音量
$71,630終了日
2026/12/31マーケット開始日
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...Current CDC travel health notices show no active Level 4 designations as of late May 2026, reflecting the absence of extreme global health risks that would justify “Avoid All Travel” advisories under agency criteria. Ongoing Ebola outbreaks in East and Central Africa have prompted targeted entry screening and 30-day restrictions rather than broad Level 4 notices, while dengue and polio alerts remain at Levels 1–2. With no confirmed surges meeting the extreme-risk threshold and routine surveillance indicating contained transmission, traders assign a 76.5% implied probability against issuance by December 31, consistent with historical patterns where Level 4 warnings have been reserved for exceptional, rapidly escalating threats.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日
外部リンクに注意してください。
外部リンクに注意してください。
よくある質問